In non-AD pathologies like frontotemporal dementia (3R tau or 4R tau) [32] and progressive supranuclear palsy (4R tau) [33], highest reference tissue model derived BPND was lower at 1.15 and 0.6 respectively, while 2-TCM data has not been published. This evidence concerns the gene MAPT and Alzheimer disease.